Molecular Templates Inc
NASDAQ:MTEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Molecular Templates Inc
NASDAQ:MTEM
|
US |
|
E
|
Eiffage SA
XBER:EF3
|
FR |
|
Dua Putra Utama Makmur Tbk PT
IDX:DPUM
|
ID |
|
M
|
MapLight Therapeutics Inc
NASDAQ:MPLT
|
US |
|
EQV Ventures Acquisition Corp
NYSE:FTW
|
US |
|
Diversified Energy Co
F:QI7
|
US |
|
Zeng Hsing Industrial Co Ltd
TWSE:1558
|
TW |
|
Dogwood Therapeutics Inc
NASDAQ:DWTX
|
US |
|
Hindcon Chemicals Ltd
NSE:HINDCON
|
IN |
|
S
|
SSE PLC
SWB:SCT
|
UK |
Balance Sheet
Balance Sheet Decomposition
Molecular Templates Inc
Molecular Templates Inc
Balance Sheet
Molecular Templates Inc
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||
| Cash & Cash Equivalents |
6
|
41
|
14
|
75
|
29
|
11
|
16
|
9
|
9
|
6
|
11
|
7
|
8
|
10
|
2
|
59
|
88
|
86
|
25
|
25
|
32
|
12
|
|
| Cash Equivalents |
6
|
41
|
14
|
75
|
29
|
11
|
16
|
9
|
9
|
6
|
11
|
7
|
8
|
10
|
2
|
59
|
88
|
86
|
25
|
25
|
32
|
12
|
|
| Short-Term Investments |
0
|
0
|
14
|
25
|
24
|
11
|
7
|
28
|
6
|
14
|
60
|
58
|
50
|
39
|
0
|
0
|
10
|
40
|
69
|
118
|
29
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
18
|
7
|
2
|
0
|
0
|
5
|
8
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
7
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
1
|
1
|
1
|
1
|
10
|
1
|
0
|
1
|
2
|
1
|
3
|
0
|
2
|
2
|
7
|
7
|
5
|
7
|
5
|
|
| Total Current Assets |
7
|
41
|
30
|
100
|
53
|
23
|
23
|
48
|
16
|
21
|
88
|
86
|
67
|
53
|
2
|
60
|
105
|
140
|
101
|
148
|
68
|
17
|
|
| PP&E Net |
0
|
0
|
2
|
2
|
3
|
2
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
2
|
7
|
28
|
33
|
28
|
26
|
17
|
|
| PP&E Gross |
0
|
0
|
2
|
2
|
3
|
2
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
2
|
7
|
28
|
33
|
28
|
26
|
17
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
2
|
3
|
4
|
4
|
5
|
2
|
2
|
2
|
2
|
3
|
0
|
0
|
1
|
3
|
7
|
14
|
21
|
27
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
27
|
27
|
0
|
1
|
1
|
1
|
1
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
9
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
2
|
5
|
4
|
6
|
3
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
7
N/A
|
41
+516%
|
32
-22%
|
102
+217%
|
57
-44%
|
26
-55%
|
25
-5%
|
49
+99%
|
16
-67%
|
22
+38%
|
90
+300%
|
104
+16%
|
68
-34%
|
54
-21%
|
3
-94%
|
90
+2 816%
|
140
+55%
|
174
+24%
|
140
-20%
|
192
+38%
|
98
-49%
|
35
-64%
|
|
| Liabilities | |||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
2
|
1
|
2
|
2
|
1
|
1
|
3
|
1
|
2
|
2
|
2
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
2
|
7
|
7
|
2
|
1
|
13
|
3
|
6
|
8
|
11
|
9
|
10
|
1
|
3
|
5
|
16
|
15
|
12
|
11
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
5
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
9
|
15
|
15
|
0
|
2
|
3
|
26
|
18
|
20
|
33
|
46
|
9
|
|
| Total Current Liabilities |
0
|
1
|
8
|
10
|
10
|
5
|
3
|
13
|
4
|
9
|
18
|
27
|
26
|
11
|
14
|
10
|
33
|
36
|
38
|
47
|
57
|
17
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
3
|
3
|
15
|
36
|
36
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
3
|
2
|
1
|
1
|
13
|
8
|
9
|
86
|
101
|
66
|
2
|
0
|
2
|
4
|
32
|
28
|
45
|
19
|
14
|
|
| Total Liabilities |
0
N/A
|
1
+175%
|
9
+700%
|
13
+44%
|
13
+1%
|
6
-52%
|
3
-50%
|
26
+739%
|
11
-57%
|
18
+59%
|
103
+474%
|
128
+23%
|
92
-28%
|
13
-86%
|
17
+33%
|
13
-23%
|
39
+200%
|
71
+81%
|
81
+13%
|
127
+57%
|
113
-11%
|
31
-72%
|
|
| Equity | |||||||||||||||||||||||
| Common Stock |
9
|
50
|
50
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
26
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
11
|
35
|
79
|
135
|
165
|
184
|
208
|
227
|
252
|
323
|
352
|
373
|
329
|
40
|
65
|
95
|
164
|
269
|
352
|
445
|
453
|
|
| Additional Paid In Capital |
0
|
3
|
25
|
180
|
183
|
186
|
205
|
230
|
231
|
257
|
309
|
328
|
349
|
370
|
1
|
142
|
196
|
267
|
328
|
418
|
430
|
457
|
|
| Other Equity |
0
|
1
|
17
|
11
|
4
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
40
+537%
|
23
-42%
|
89
+282%
|
44
-51%
|
20
-56%
|
21
+9%
|
23
+6%
|
5
-78%
|
5
-8%
|
14
N/A
|
24
-69%
|
24
-2%
|
41
N/A
|
14
N/A
|
77
N/A
|
101
+31%
|
103
+2%
|
59
-42%
|
66
+11%
|
15
N/A
|
4
N/A
|
|
| Total Liabilities & Equity |
7
N/A
|
41
+516%
|
32
-22%
|
102
+217%
|
57
-44%
|
26
-55%
|
25
-5%
|
49
+99%
|
16
-67%
|
22
+38%
|
90
+300%
|
104
+16%
|
68
-34%
|
54
-21%
|
3
-94%
|
90
+2 816%
|
140
+55%
|
174
+24%
|
140
-20%
|
192
+38%
|
98
-49%
|
35
-64%
|
|
| Shares Outstanding | |||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
3
|
4
|
4
|
5
|
|